Literature DB >> 3203484

Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.

K W Woodhouse1, H A Wynne.   

Abstract

The propensity of elderly people to suffer from dose-dependent adverse drug reactions is well known. This may be largely related to reduced drug clearance. Changes in liver size and liver blood flow are probably the main reason for this decline in drug elimination with age. This review focuses on methods of measuring liver size and blood flow, on changes which have been reported in the elderly and on the clinical implications of these changes.

Entities:  

Mesh:

Year:  1988        PMID: 3203484     DOI: 10.2165/00003088-198815050-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  70 in total

1.  Liver blood flow and blood volume following chronic phenobarbitone administration.

Authors:  E E Ohnhaus; J T Locher
Journal:  Eur J Pharmacol       Date:  1975-04       Impact factor: 4.432

2.  VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.

Authors:  R KATO; P VASSANELLI; G FRONTINO; E CHIESARA
Journal:  Biochem Pharmacol       Date:  1964-07       Impact factor: 5.858

3.  The use of indocyanine green for the evaluation of hepatic function and blood flow in man.

Authors:  B D WIEGAND; S G KETTERER; E RAPAPORT
Journal:  Am J Dig Dis       Date:  1960-05

4.  The disappearance rate of colloidal radio-gold from the circulation and its application to the estimation, of liver blood flow in normal and cirrhotic subjects.

Authors:  H VETTER; R FALKNER; A NEUMAYR
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

5.  Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals.

Authors:  W G SCHENK; J C McDONALD; K McDONALD; T DRAPANAS
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

6.  Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

7.  Effect of age on the hepatic clearance of propranolol in rats.

Authors:  K Iwamoto; J Watanabe; K Araki; N Deguchi; H Sugiyama
Journal:  J Pharm Pharmacol       Date:  1985-07       Impact factor: 3.765

8.  Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance.

Authors:  M Schnegg; B H Lauterburg
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

9.  Evaluation of liver volume and liver function following hepatic resection in man.

Authors:  M Zoli; G Marchesini; A Melli; G Viti; A Marra; D Marrano; E Pisi
Journal:  Liver       Date:  1986-10

10.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01
View more
  36 in total

Review 1.  Drug metabolism and ageing.

Authors:  M T Kinirons; M S O'Mahony
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin.

Authors:  H Cheng; J D Rogers; A E Sweany; M R Dobrinska; E A Stein; A C Tate; R D Amin; H Quan
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

Review 3.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 4.  Predicting risk of adverse drug reactions in older adults.

Authors:  Amanda Hanora Lavan; Paul Gallagher
Journal:  Ther Adv Drug Saf       Date:  2016-02

5.  Quality indicators for in-hospital pharmaceutical care of Dutch elderly patients: development and validation of an ACOVE-based quality indicator set.

Authors:  Peter C Wierenga; Joanna E Klopotowska; Susanne M Smorenburg; Hendrikus J van Kan; Yuma A Bijleveld; Marcel G Dijkgraaf; Sophia E de Rooij
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

Review 6.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway.

Authors:  Katarzyna Furrer; Andreas Rickenbacher; Yinghua Tian; Wolfram Jochum; Anne Greet Bittermann; Andres Käch; Bostjan Humar; Rolf Graf; Wolfgang Moritz; Pierre-Alain Clavien
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

8.  The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.

Authors:  B T Veering; A G Burm; J H Souverijn; J M Serree; J Spierdijk
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

9.  Lack of effect of ageing on the stereochemical disposition of propranolol.

Authors:  H H Zhou; E Whelan; A J Wood
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

10.  Surgical treatment of liver metastases from colorectal cancer in elderly patients.

Authors:  Gianluca Mazzoni; Adriano Tocchi; Michelangelo Miccini; Elia Bettelli; Diletta Cassini; Monica De Santis; Lidia Colace; Stefania Brozzetti
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.